Charles River Laboratories International (CRL) Total Non-Current Liabilities (2009 - 2026)

Charles River Laboratories International has reported Total Non-Current Liabilities for 18 years, with the latest figure at $4.2 billion in Q2 2026.

• On a quarterly basis, Total Non-Current Liabilities rose 6.67% year-over-year to $4.2 billion in Q2 2026; TTM through Jun 2026 was $4.2 billion, a 6.67% increase from a year earlier, with the FY2025 full-year figure at $3.8 billion, down 1.02% from the prior year.
• Total Non-Current Liabilities was $4.2 billion for Q2 2026 at Charles River Laboratories International, roughly flat from $4.2 billion in the prior quarter.
• The five-year high for Total Non-Current Liabilities was $4.6 billion in Q2 2022, with the low at $3.8 billion in Q4 2025.
• Average Total Non-Current Liabilities over 5 years is $4.2 billion, with a median of $4.2 billion recorded in 2022.
• The sharpest annual moves came in 2022 and 2024: Total Non-Current Liabilities rose 23.03% in 2022, then slipped 11.31% in 2024.
• Over 5 years, Total Non-Current Liabilities stood at $4.4 billion in 2022, then fell by 2.08% to $4.3 billion in 2023, then slipped by 11.31% to $3.8 billion in 2024, then dropped by 1.02% to $3.8 billion in 2025, then advanced by 12.02% to $4.2 billion in 2026.
• The last three Total Non-Current Liabilities figures came in at $4.2 billion (Q2 2026), $4.2 billion (Q1 2026), and $3.8 billion (Q4 2025), per Business Quant data.